Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota.

This study affirms that dysbiosis is a feature of RA. Although patients were not randomized to MTX or TNFi, the findings suggest that specific therapies may differentially modulate the gastrointestinal microbiota in RA. The association between P. copri and treatment response requires further study.